Adalimumab-induced lupus erythematosus |
| |
Authors: | Martín J M Ricart J M Alcácer J Rausell N Arana G |
| |
Affiliation: | Department of Dermatology, Hospital Clínico Universitario, Valencia, Spain. jmmart@eresmas.com |
| |
Abstract: | Adalimumab, an anti-tumour necrosis factor agent, especially used in the treatment of rheumatoid arthritis, has a good safety profile. One of the most common side-effects of adalimumab is the development of autoantibodies. Despite the induction of autoantibodies, the clinical presentation of immune-mediated complications upon adalimumab therapy, including a lupus-like syndrome, is very rare. We have recently evaluated a new case of adalimumab-induced lupus erythematosus. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|